ASP Isotopes Inc. (ASPI)
| Market Cap | 338.81M -74.2% |
| Revenue (ttm) | 30.85M +573.4% |
| Net Income | -132.05M |
| EPS | -1.22 |
| Shares Out | 153.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,834,840 |
| Open | 2.170 |
| Previous Close | 2.070 |
| Day's Range | 2.030 - 2.220 |
| 52-Week Range | 2.030 - 13.750 |
| Beta | 3.70 |
| Analysts | Strong Buy |
| Price Target | 13.00 (+488.24%) |
| Est. Earnings | Nov 18, 2026 |
About ASPI
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages... [Read more]
Financial Performance
In 2025, ASP Isotopes's revenue was $23.85 million, an increase of 475.51% compared to the previous year's $4.14 million. Losses were -$175.09 million, 398.6% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for ASPI stock is "Strong Buy." The 12-month stock price target is $13.0, which is an increase of 488.24% from the latest price.
News
Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa
Joint Venture Supported by Offtake Agreements with TerraPower, Initial Regulatory Approvals, and Access to Site Infrastructure to enable QLE and Necsa to Advance Toward Commercial-Scale HALEU Producti...
Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
ASP Isotopes Transcript: CMD 2026
The company is transitioning from development to global scaling, targeting $300–$700 million EBITDA by 2031 through expansion in radiopharmaceuticals, isotope enrichment, helium/LNG, and nuclear fuel. Proprietary technology, vertical integration, and asset spin-outs underpin growth, with strong financial resources and robust demand in structurally short markets.
ASP Isotopes Slides: FY 2026
ASP Isotopes has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 8, 2026.
ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update
DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critic...
ASP Isotopes Transcript: Emerging Growth Conference
The company is advancing commercial production across isotope enrichment, helium, and LNG, with major South African assets positioned to address global supply shortages in semiconductors, nuclear medicine, and energy. Phase one production has begun, with significant revenue and EBITDA growth expected by 2031.
ASP Isotopes says Renergen begins commissioning of South Africa helium plant
ASP Isotopes (ASPI) announced that Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered the commissioning phase of the company’s liquid helium plant. The…
ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is e...
ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia
DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedic...
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring...
ASP Isotopes Quarterly report: Q2 2026
ASP Isotopes has published its Q2 2026 quarterly earnings report on August 14, 2026.
ASP Isotopes Transcript: Canaccord Genuity's 46th Annual Growth Conference
The company is expanding its vertically integrated isotope and helium production, targeting electronics, nuclear medicine, and energy markets. Major projects include U.S. radiopharmacy acquisitions, a large-scale helium facility, and new nuclear fuel technologies, with significant revenue and EBITDA growth expected by 2031.
ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, ...
ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference
DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pro...
ASP Isotopes Issues Letter to Shareholders
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for...
ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the pro...
ASP Isotopes to Hold Capital Markets Day on September 8
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the pro...
ASP Isotopes Transcript: Investor update
Noble Africa is advancing a world-class helium project in South Africa, with phase I plant completion and first shipments expected by September. The company benefits from unique geology, strong funding, and long-term contracts amid global supply shortages. Phase II will significantly expand capacity by 2031, positioning the firm as a leading pure-play helium producer.
ASP Isotopes subsidiary signs research deal with Texas state agency
ASP Isotopes (ASPI) announced that its wholly owned subsidiary, Quantum Leap Energy, has signed a research agreement with the Texas A&M Engineering Experiment Station to advance and de-risk the commer...
ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology
DALLAS, July 21, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedic...
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or “ASPI”), an advanced materials company focused on developing technologies and processes...
ASP Isotopes files to sell 23.16M shares of common stock for holders
17:02 EDT ASP Isotopes (ASPI) files to sell 23.16M shares of common stock for holders
ASP Isotopes to exchange certain QLE convertible notes for ASPI common stock
ASP Isotopes (ASPI) announced that ASPI and Quantum Leap Energy, a wholly-owned subsidiary of ASPI, have entered into separate, individually negotiated private exchange agreements with certain holders...
ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock
Exchange reduces QLE's outstanding convertible notes by approximately 50% as QLE continues to pursue a public listing as a separate company Exchange reduces QLE's outstanding convertible notes by appr...
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," “ASPI” or the "Company"), an advanced materials company focused on developing technologie...